PB Fintech to Invest ₹696 Crore in Subsidiary PB Healthcare Services

PB Fintech Ltd, the parent company of Policybazaar, has announced its plan to invest up to ₹696 crore in PB Healthcare Services Private Limited, its wholly owned subsidiary. This investment, which will be executed through the purchase or subscription of equity shares and compulsory convertible preference shares (CCPS), is expected to take place during the financial year 2025-26. The move is aimed at strengthening PB Healthcare’s operations and accelerating its expansion in the healthcare and allied services sector.

Investment Structure and Shareholder Approval

PB Fintech’s investment in PB Healthcare Services is subject to approval from its shareholders via a postal ballot. The funding will be made alongside contributions from external investors, including Chairman & CEO Yashish Dahiya, Executive Vice Chairman Alok Bansal, and three Key Managerial Personnel (KMPs).

Following the transaction, PB Fintech will hold up to 33.63% of PB Healthcare’s equity on a fully diluted basis. Since the acquisition is classified as a related party transaction, it will be executed at a fair valuation determined by a Registered Valuer.

Strategic Objectives and Business Expansion

PB Healthcare Services was incorporated in January 2025 and operates within the healthcare and allied services industry. The fresh capital infusion aims to cover operational expenses, enhance brand visibility, and fund strategic initiatives to strengthen the subsidiary’s market presence.

With this investment, PB Fintech is positioning itself to play a significant role in the evolving healthcare landscape. The company seeks to leverage its expertise and financial resources to drive sustainable growth and innovation within its subsidiary.

PB Fintech Share Performance

As of March 11, 2025, at 10:32 AM, the shares of PB Fintech are trading at ₹1,397.40 per share, down by 4.78% from the previous closing price.

Conclusion

PB Fintech’s decision to invest ₹696 crore in PB Healthcare Services highlights its commitment to expanding into the healthcare sector. With shareholder backing and participation from key executives, this investment is expected to enhance operational capabilities, increase market competitiveness, and support long-term business growth.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.